Business
Hemogenyx Welcomes N.Y. Lt. Governor to its Labs
Hemogenyx Welcomes N.Y. Lt. Governor to its Labs.
About this update from Hemogenyx Pharmaceuticals Plc
[{"type":"text","content":"\n \nRNS Number : 5520B Hemogenyx Pharmaceuticals PLC 11 January 2018 \n\n \nHemogenyx Pharmaceuticals Plc\n(\"Hemogenyx\" or the \"Company\")\n \nHemogenyx Welcomes N.Y. Lt. Governor to its Labs\n \nAdvanced biotech startup touts ground-breaking medical research, deep ties to New York State.\n \n \nHemogenyx Pharmaceuticals Plc (LSE: HEMO), the biotechnology company developing novel therapies to transform bone marrow, or blood stem cell, transplantation for the treatment of blood diseases, welcomed New York Lieutenant Governor Kathy Hochul to its labs at the SUNY Downstate Medical Center Biotech Incubator.\n \nIn addition to showing Hochul its cutting-edge facilities, Hemogenyx also briefed the Lieutenant Governor on its advanced technologies-and their potential to save lives.\n \n\"As a biotech company with its roots in New York, we were honored to welcome Lieutenant Governor Hochul to our labs,\" said Dr. Vladislav Sandler, CEO of Hemogenyx. Hemogenyx, which went public last year on the London Stock Exchange, opened its first lab in Buffalo after winning the New York-state funded 43North business competition. Now its four scientists work out of two state-of-the-art labs inside SUNY Downstate Medical Center's Biotech Incubator. \"Having access to the high-quality facilities at SUNY Downstate has been instrumental to our success in creating a safer and more effective approach to bone marrow transplants,\" added Dr. Sandler.\n \n\"By providing biotech businesses with state-of-the-art laboratory space and financial support in the early stages, the SUNY Downstate Biotech Incubator is setting them up with the tools they need to grow into our next entrepreneurial success stories,\" said Lieutenant Governor Hochul. \"Hemogenyx Pharmaceuticals is one such success story, launching their business in New York State with the 43 North Startup competition and continuing to expand at SUNY Downstate's world-class facilities.\"\n \nHochul's visit to Hemogenyx was part of a larger tour of the SUNY Downstate Biotech Incubator. After seeing the facility, the Lieutenant Governor gave a special presentation of Governor Cuomo's State of the State address.\n \n \nEnquiries:\n \n\n\n\n\nHemogenyx Pharmaceuticals Limited\n\n\nwww.hemogenyx.com\n\n\n\n\nDr Vladislav Sandler, Chief Executi...